Increased Serum Phospholipase A2 Activity After Non-Heart-Beating Donor Liver Transplantation and Association With Ischemia-Reperfusion Injury

Journal of Surgical Research

Volumn 151, Issue 1, 2009, Pages 125-131

  Monbaliu, Diethard R L ^a   Dubuisson, Christel N T ^a   Zeegers, Marcel M M ^a   Crabbé, Martine M J ^a   Fevery, Johan M J ^a   Pirenne, Jacques M F ^a   van Pelt, Jos F ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

liver; non heart beating donors; phospholipase A2

Indexed keywords

INTERLEUKIN 6; PHOSPHOLIPASE A2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; ENZYME ACTIVITY; LIVER ISCHEMIA; LIVER TRANSPLANTATION; NONHUMAN; ORGAN DONOR; PRIORITY JOURNAL; REPERFUSION INJURY; SWINE;

ANIMALS; DISEASE MODELS, ANIMAL; INTERLEUKIN-6; LIVER; LIVER TRANSPLANTATION; PHOSPHOLIPASES A2; POSTOPERATIVE COMPLICATIONS; REPERFUSION INJURY; SWINE; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 57149098626     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2008.01.034     Document Type: Article

References (34)

1. Teoh N.C., and Farrell G.C. Hepatic ischemia reperfusion injury: Pathogenic mechanisms and basis for hepatoprotection. J Gastroenterol Hepatol 18 (2003) 891
2. Farmer D.G., Amersi F., Kupiec-Weglinski J., et al. Current status of ischemia and reperfusion injury in the liver. Transplant Rev 14 (2000) 106
3. Casillas-Ramirez A., Mosbah I.B., Ramalho F., et al. Past and future approaches to ischemia-reperfusion lesion associated with liver transplantation. Life Sci 79 (2006) 1881
4. Monbaliu D., de Vries B., Crabbe T., et al. Liver fatty acid-binding protein: An early and sensitive plasma marker of hepatocellular damage and a reliable predictor of graft viability after liver transplantation from non-heart-beating donors. Transplant Proc 37 (2005) 413
5. Sato M., Ohkohchi N., Tsukamoto S., et al. Successful liver transplantation from agonal non-heart-beating donors in pigs. Transpl Int 16 (2003) 100
6. Monbaliu D., van Pelt J., De Vos R., et al. Primary graft nonfunction and Kupffer cell activation after liver transplantation from non-heart-beating donors in pigs. Liver Transpl 13 (2007) 239
7. Granata F., Balestrieri B., Petraroli A., et al. Secretory phospholipases A2 as multivalent mediators of inflammatory and allergic disorders. Int Arch Allergy Immunol 131 (2003) 153
8. Touqui L., and Alaoui-El-Azher M. Mammalian secreted phospholipases A2 and their pathophysiological significance in inflammatory diseases. Curr Mol Med 1 (2001) 739
9. Laye J.P., and Gill J.H. Phospholipase A2 expression in tumours: A target for therapeutic intervention?. Drug Discov Today 8 (2003) 710
10. Sonnino R.E., Pigatt L., Burchett S., et al. Role of secretory phospholipase A2 (SPLA2) in ischemic injury to intestinal grafts during 24-hour preservation. Transplant Proc 28 (1996) 2603
11. Webb N.R. Secretory phospholipase A2 enzymes in atherogenesis. Curr Opin Lipidol 16 (2005) 341
12. Koike K., Yamamoto Y., Hori Y., et al. Group IIA phospholipase A2 mediates lung injury in intestinal ischemia-reperfusion. Ann Surg 232 (2000) 90
13. Ogata K., Jin M.B., Taniguchi M., et al. Attenuation of ischemia and reperfusion injury of canine livers by inhibition of type II phospholipase A2 with LY329722. Transplantation 71 (2001) 1040
14. Murakami M., and Kudo I. Phospholipase A2. J Biochem (Tokyo) 131 (2002) 285
15. Menschikowski M., Hagelgans A., and Siegert G. Secretory phospholipase A2 of group IIA: Is it an offensive or a defensive player during atherosclerosis and other inflammatory diseases?. Prostaglandins Other Lipid Mediat 79 (2006) 1
16. 2 renders cells accessible to lysis by exogenous phospholipase A2: a novel mechanism for cell damage in inflammatory processes. FEBS Lett 383 (1996) 75
17. Murakami M., Nakatani Y., Atsumi G., et al. Regulatory functions of phospholipase A2. Crit Rev Immunol 17 (1997) 225
18. Oikawa K., Ohkohchi N., Sato M., et al. Kupffer cells play an important role in the cytokine production and activation of nuclear factors of liver grafts from non-heart-beating donors. Transpl Int 15 (2002) 397
19. Murakami M., Kambe T., Shimbara S., et al. Functional association of type IIA secretory phospholipase A(2) with the glycosylphosphatidylinositol-anchored heparan sulfate proteoglycan in the cyclooxygenase-2-mediated delayed prostanoid-biosynthetic pathway. J Biol Chem 274 (1999) 29927
20. Crowl R.M., Stoller T.J., Conroy R.R., et al. Induction of phospholipase A2 gene expression in human hepatoma cells by mediators of the acute phase response. J Biol Chem 266 (1991) 2647
21. Mukherjee A.B., Cordella-Miele E., and Miele L. Regulation of extracellular phospholipase A2 activity: Implications for inflammatory diseases. DNA Cell Biol 11 (1992) 233
22. Monbaliu D., Crabbe T., Roskams T., et al. Livers from non-heart-beating donors tolerate short periods of warm ischemia. Transplantation 79 (2005) 1226
23. Pernas P., Masliah J., Olivier J.L., et al. Type II phospholipase A2 recombinant overexpression enhances stimulated arachidonic acid release. Biochem Biophys Res Commun 178 (1991) 1298
24. Pfeilschifter J., Schalkwijk C., Briner V.A., et al. Cytokine-stimulated secretion of group II phospholipase A2 by rat mesangial cells. Its contribution to arachidonic acid release and prostaglandin synthesis by cultured rat glomerular cells. J Clin Invest 92 (1993) 2516
25. St Peter S.D., Imber C.J., de Cenarruzabeitia I.L., et al. Beta-galactosidase as a marker of ischemic injury and a mechanism for viability assessment in porcine liver transplantation. Liver Transpl 8 (2002) 21
26. Ikemoto M., Tsunekawa S., Toda Y., et al. Liver-type arginase is a highly sensitive marker for hepatocellular damage in rats. Clin Chem 47 (2001) 946
27. Bowen R.S., Zhang Y., Gu Y., et al. Increased phospholipase A2 and thromboxane but not prostacyclin production by placental trophoblast cells from normal and preeclamptic pregnancies cultured under hypoxia condition. Placenta 26 (2005) 402
28. Jameel N.M., Frey B.M., Frey F.J., et al. Inhibition of secretory phospholipase A(2) enzyme by bilirubin: A New role as endogenous anti-inflammatory molecule. Mol Cell Biochem 276 (2005) 219
29. Buckland A.G., and Wilton D.C. Inhibition of secreted phospholipases A2 by annexin V. Competition for anionic phospholipid interfaces allows an assessment of the relative interfacial affinities of secreted phospholipases A2. Biochim Biophys Acta 1391 (1998) 367
30. Guy J., Dhanireddy R., and Mukherjee A.B. Surfactant-producing rabbit pulmonary alveolar type II cells synthesize and secrete an antiinflammatory protein uteroglobin. Biochem Biophys Res Commun 189 (1992) 662
31. Jorens P.G., Sibille Y., Goulding N.J., et al. Potential role of clara cell protein, an endogenous phospholipase A2 inhibitor, in acute lung Injury. Eur Respir J 8 (1995) 1647
32. Takasaki J., Kawauchi Y., Urasaki T., et al. Antibodies against type II phospholipase A2 prevent renal injury due to ischemia and reperfusion in rats. FEBS Lett 440 (1998) 377
33. Goto S., Nakamura H., Morooka H., et al. Role of reactive oxygen in phospholipase A2 activation by ischemia/reperfusion of the rat kidney. J Anesth 13 (1999) 90
34. Abraham E., Naum C., Bandi V., et al. Efficacy and safety of LY315920Na/S-5920, a selective inhibitor of 14-KDa group IIA secretory phospholipase A2, in patients with suspected sepsis and organ failure. Crit Care Med 31 (2003) 718